Post COVID-19 Condition

Condition(s) studied

Investigational drug(s) / intervention(s)

follow up of COVID-19 Patients: In each participating center a post COVID-19 outpatient clinic is already working or will be settled up to care COVID-19 patients after the acute phase. At the post COVID-19 clinic patients will undergo routine blood exams and will be visited by Infectious Diseases physicians after recovery from the acute episode of COVID-19 disease. According to the clinical issues of the patients and the procedures of the study, if necessary, the patients will be visited by other practitioners (Pneumologists, Cardiologists, Neurologists, Physiatrist and Psychologists or others). Patients who have been already visited at the post COVID outpatient clinics from 01/03/2020 and for whom data of the acute phase and the follow up have been collected will be enrolled in the study and retrospectively analyzed.

Study summary

The EuCARE-POSTCOVID study is an observational multicentre study enrolling COVID-19 patients recovered from the acute phase of disease to investigate the prevalence and possible predictors of post COVID-19 condition. The study will retrospectively analyze data already collected at the post COVID-19 outpatients services of the participating centers; furthermore, a prospective cohort study will be performed.

Eligibility

Primary outcome measure(s)

• Overall incidence of post COVID-19 condition — through study completion, an average of 3 years
• Persistence of post COVID-19 condition beyond 2-3 months from the acute COVID-19 disease — through study completion, an average of 3 years
• Predictors of post COVID-19 condition — through study completion, an average of 3 years
• Long-term organ damage (lung, heart, Central Nervous System, Peripheral Nervous System) associated with post COVID-19 condition — through study completion, an average of 3 years
• Virological and immunological phenotype of post COVID-19 condition — through study completion, an average of 3 years

Trial sites (7)

More Euresist Network GEIE trials in Italy

Other trials for the same condition